Anthropic Claude for Life Sciences accelerates research with new tools and partnerships

TL;DR

Claude for Life Sciences, now running on the Opus 4.5 model, is being deployed in custom AI agents such as Stanford’s Biomni, MIT’s MozzareLLM, and Stanford’s Lundberg Lab hypothesis generator, cutting weeks‑long workflows down to minutes and enabling new research strategies.

Claude for Life Sciences – a rapid upgrade

Anthropic released Claude for Life Sciences in October 2023, adding connectors and domain‑specific skills. Since then the company has upgraded the underlying model to Opus 4.5, which shows measurable gains on benchmarks for figure interpretation, computational biology, and protein understanding. These improvements stem from close collaborations with academic and industry researchers and are reflected in the performance of downstream systems built on Claude.

AI for Science program – free API credits for high‑impact projects

Anthropic’s AI for Science program supplies free Claude API credits to leading researchers worldwide. The program is designed to lower the barrier to entry for scientific teams that want to experiment with Claude‑powered agents on ambitious projects.

Biomni – a general‑purpose biomedical agent

What Biomni does

Biomni, developed at Stanford, aggregates hundreds of databases, software packages, and protocols into a single Claude‑driven interface. Users submit plain‑language requests; Biomni selects the appropriate tools, formulates hypotheses, designs experiments, and runs analyses across more than 25 biological subfields.

Real‑world impact

  • In a GWAS workflow, Biomni reduced a process that normally takes months to 20 minutes.
  • Validation studies showed:
    • Molecular cloning protocol design matched that of an experienced postdoc.
    • Analysis of 450 wearable‑device files (glucose, temperature, activity) was completed in 35 minutes, a task that would require three weeks for a human expert.
    • Gene‑activity analysis of 336 k single‑cell profiles reproduced known regulatory relationships and uncovered new transcription‑factor links in human embryonic development.

Limitations and guardrails

Biomni includes detection mechanisms to flag when Claude deviates from expected behavior. When Claude’s default reasoning is insufficient, researchers can encode expert workflows as Claude skills, teaching the agent domain‑specific methods.

MozzareLLM – automating interpretation of large‑scale CRISPR knockout screens

The bottleneck addressed

The Cheeseman Lab at MIT generates thousands of gene knockouts and images of resulting cellular phenotypes. While software can cluster genes by visual similarity, interpreting those clusters still required manual literature mining.

Claude‑powered solution

Graduate student Matteo Di Bernardo built MozzareLLM, a Claude‑driven system that:

  • Takes a gene cluster and returns likely shared biological processes.
  • Flags well‑studied versus poorly characterized genes.
  • Provides confidence scores for each inference, guiding resource allocation.

Performance highlights

  • Claude outperformed alternative models, correctly identifying an RNA‑modification pathway that other models dismissed as noise.
  • Researchers reported that Claude consistently surfaced insights they had missed, leading to verifiable new discoveries.
  • The team plans to publish Claude‑annotated datasets, enabling external labs to explore under‑investigated gene clusters.

Lundberg Lab – AI‑driven hypothesis generation for focused screens

Traditional approach

Target selection for focused CRISPR screens relies on manual curation of candidate genes in spreadsheets, a process limited by human memory and literature bias.

Claude‑enabled workflow

The Lundberg Lab constructed a comprehensive molecular relationship map (proteins, RNAs, DNA) and tasked Claude with navigating this graph to propose gene candidates based on intrinsic molecular properties rather than prior study prevalence.

Ongoing experiment

  • The lab selected primary cilia—a poorly characterized cellular structure—as a test case.
  • Claude will generate a candidate list, which will be compared against a human‑curated list in a whole‑genome screen.
  • Preliminary metrics will assess recall (e.g., Claude identifying 150/200 true hits versus 80/200 for humans) and speed.

Potential impact

If successful, Claude’s hypothesis generation could become a standard pre‑screen step, allowing labs to make data‑driven bets on gene targets without the expense of whole‑genome screens.

Broader implications for scientific research

  • Speed and cost reduction – Tasks that previously required weeks of expert labor are now completed in minutes, dramatically lowering research overhead.
  • New research avenues – By removing bottlenecks, Claude enables scientists to pursue experiments that were previously infeasible due to resource constraints.
  • Iterative improvement – Each new Claude model release brings noticeable capability gains, turning AI from a peripheral assistant into a core research partner.
  • Community expansion – Open‑source tools like MozzareLLM and the publicly available Biomni platform encourage broader adoption and collaborative refinement.

Looking ahead

Anthropic emphasizes that these systems are not perfect; guardrails, expert‑encoded skills, and human oversight remain essential. Nonetheless, the rapid adoption across diverse labs demonstrates a clear trend: AI agents are moving from simple literature summarization toward end‑to‑end scientific collaboration, reshaping how experiments are designed, executed, and interpreted.

For more details on Claude for Life Sciences capabilities, see the Claude solutions page and related tutorials. Applications to the AI for Science program are still open.

Sources

Related